Precigen, Inc.
Status: Publicly traded
Direct answer
Precigen, Inc. is publicly traded on NASDAQ under the ticker PGEN.
Precigen, Inc. is an American company dedicated to the discovery and development of cutting-edge gene and cellular therapies. The company also offers disease-modifying treatments, genetically engineered swine for regenerative medicine, and advanced reproductive and embryo transfer technologies. Its extensive portfolio of proprietary platforms includes UltraVector, which leverages advanced DNA construction and...
Can you invest in Precigen, Inc.?
Yes. Precigen, Inc. trades publicly on NASDAQ as PGEN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Precigen, Inc.
Detailed equity research is provided by MarketSnap.